Cost-Effectiveness of Newer Antiretroviral Drugs in Treatment-Experienced Patients With Multidrug-Resistant HIV Disease-Reference-Cited by-同舟云学术

Cost-Effectiveness of Newer Antiretroviral Drugs in Treatment-Experienced Patients With Multidrug-Resistant HIV Disease

Published:2013-12-01 Issue:4 Volume:64 Page:382-391
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Bayoumi Ahmed M.,Barnett Paul G.,Joyce Vilija R.,Griffin Susan C.,Sun Huiying,Bansback Nick J.,Holodniy Mark,Sanders Gillian,Brown Sheldon T.,Kyriakides Tassos C.,Angus Brian,Cameron D. William,Anis Aslam H.,Sculpher Mark,Owens Douglas K.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference45 articles.

1. . Approach to salvage antiretroviral therapy in heavily antiretroviral-experienced HIV-positive adults.;Temesgen;Lancet Infect Dis,2006

2. . Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen.;Cozzi-Lepri;AIDS,2007

3. . Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America.;Deeks;Clin Infect Dis,2009

4. . Results of antiretroviral treatment interruption and intensification in advanced multi-drug resistant HIV infection from the OPTIMA trial.;Holodniy;PLoS One,2011

5. . Quality of life of patients with advanced HIVAIDS: measuring the impact of both AIDS-defining events and non-AIDS serious adverse events.;Anis;J Acquir Immune Defic Syndr,2009

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment (As Prevention) Availability and Individual’s Endogenous Behavior: A Cost-Effectiveness Analysis of Long-Acting Injectable PrEP;SSRN Electronic Journal;2023

2. Evaluating the use of dose-sparing vaccination strategies for Monkeypox;2022-11-10

3. Transitioning women to first-line preferred TLD regimen is lagging in Sub-Saharan Africa;Clinical Infectious Diseases;2022-07-05

4. Estimating HIV Management and Comorbidity Costs Among Aging HIV Patients in the United States: A Systematic Review;Journal of Managed Care & Specialty Pharmacy;2020-02

5. Competing biomedical HIV prevention strategies: potential cost‐effectiveness of HIV vaccines and PrEP in Seattle, WA;Journal of the International AIDS Society;2019-08